1
|
Yadegari F, Gabler Pizarro LA, Marquez-Curtis LA, Elliott JAW. Temperature Dependence of Membrane Permeability Parameters for Five Cell Types Using Nonideal Thermodynamic Assumptions to Mathematically Model Cryopreservation Protocols. J Phys Chem B 2024; 128:1139-1160. [PMID: 38291962 PMCID: PMC10860702 DOI: 10.1021/acs.jpcb.3c04534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2023] [Revised: 10/15/2023] [Accepted: 11/17/2023] [Indexed: 02/01/2024]
Abstract
Cryopreservation is the process of preserving biological matter at subzero temperatures for long-term storage. During cryopreservation, cells are susceptible to various injuries that can be mitigated by controlling the cooling and warming profiles and cryoprotective agent (CPA) addition and removal procedures. Mathematical modeling of the changing cell volume at different temperatures can greatly reduce the experiments needed to optimize cryopreservation protocols. Such mathematical modeling requires as inputs the cell membrane permeabilities to water and CPA and the osmotically inactive fraction of the cell. Since the intra- and extracellular solutions are generally thermodynamically nonideal, our group has been incorporating the osmotic virial equation to model the solution thermodynamics that underlie the cell volume change equations, adding the second and third osmotic virial coefficients of the grouped intracellular solute to the cell osmotic parameters that must be measured. In our previous work, we reported methods to obtain cell osmotic parameters at room temperature by fitting experimental cell volume kinetic data with equations that incorporated nonideal solution thermodynamics assumptions. Since the relevant cell volume excursions occur at different temperatures, the temperature dependence of the osmotic parameters plays an important role. In this work, we present a new two-part fitting method to obtain five cell-type-specific parameters (water permeability, dimethyl sulfoxide permeability, osmotically inactive fraction, and the second and third osmotic virial coefficients of the intracellular solution) from experimental measurements of equilibrium cell volume and cell volume as a function of time at room temperature and 0 °C for five cell types, namely, human umbilical vein endothelial cells (HUVECs), H9c2 rat myoblasts, porcine corneal endothelial cells (PCECs), the Jurkat T-lymphocyte cell line, and human cerebral microvascular endothelial cells (hCMECs/D3 cell line). The fitting method in this work is based on both equilibrium and kinetic cell volume data, enabling us to solve some technical challenges and expand our previously reported measurement technique to 0 °C. Finally, we use the measured parameters to model the cell volume changes for a HUVEC cryopreservation protocol to demonstrate the impact of the nonideal thermodynamic assumptions on predicting the changing cell volume during freezing and thawing.
Collapse
Affiliation(s)
- Faranak Yadegari
- Department
of Chemical and Materials Engineering, University
of Alberta, Edmonton, AB, T6G 1H9, Canada
- Department
of Laboratory Medicine and Pathology, University
of Alberta, Edmonton, AB, T6G 1C9, Canada
| | - Laura A. Gabler Pizarro
- Department
of Chemical and Materials Engineering, University
of Alberta, Edmonton, AB, T6G 1H9, Canada
| | - Leah A. Marquez-Curtis
- Department
of Chemical and Materials Engineering, University
of Alberta, Edmonton, AB, T6G 1H9, Canada
- Department
of Laboratory Medicine and Pathology, University
of Alberta, Edmonton, AB, T6G 1C9, Canada
| | - Janet A. W. Elliott
- Department
of Chemical and Materials Engineering, University
of Alberta, Edmonton, AB, T6G 1H9, Canada
- Department
of Laboratory Medicine and Pathology, University
of Alberta, Edmonton, AB, T6G 1C9, Canada
| |
Collapse
|
2
|
Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin. Molecules 2022; 27:molecules27227740. [PMID: 36431851 PMCID: PMC9693198 DOI: 10.3390/molecules27227740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2022] [Revised: 11/01/2022] [Accepted: 11/06/2022] [Indexed: 11/12/2022] Open
Abstract
Cantharidin (CTD) is the main active ingredient isolated from Mylabris, and norcantharidin (NCTD) is a demethylated derivative of CTD, which has similar antitumor activity to CTD and lower toxicity than CTD. However, the clinical use of NCTD is limited due to its poor solubility, low bioavailability, and toxic effects on normal cells. To overcome these shortcomings, researchers have explored a number of strategies, such as chemical structural modifications, microsphere dispersion systems, and nanodrug delivery systems. This review summarizes the structure-activity relationship of NCTD and novel strategies to improve the solubility and bioavailability of NCTD as well as reduce the toxicity. This review can provide evidence for further research of NCTD.
Collapse
|
3
|
Pan MS, Cao J, Fan YZ. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities. Chin Med 2020; 15:55. [PMID: 32514288 PMCID: PMC7260769 DOI: 10.1186/s13020-020-00338-6] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2020] [Accepted: 05/25/2020] [Indexed: 02/07/2023] Open
Abstract
Norcantharidin (NCTD) is a demethylated derivative of cantharidin, which is an anticancer active ingredient of traditional Chinese medicine, and is currently used clinically as a routine anti-cancer drug in China. Clarifying the anticancer effect and molecular mechanism of NCTD is critical for its clinical application. Here, we summarized the physiological, chemical, pharmacokinetic characteristics and clinical applications of NCTD. Besides, we mainly focus on its potential multi-target anticancer activities and underlying mechanisms, and discuss the problems existing in clinical application and scientific research of NCTD, so as to provide a potential anticancer therapeutic agent for human malignant tumors.
Collapse
Affiliation(s)
- Mu-Su Pan
- Department of Surgery, Tongji Hospital, Tongji University School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065 People’s Republic of China
| | - Jin Cao
- Department of Surgery, Tongji Hospital, Tongji University School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065 People’s Republic of China
| | - Yue-Zu Fan
- Department of Surgery, Tongji Hospital, Tongji University School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065 People’s Republic of China
| |
Collapse
|
4
|
Yang T, Peng J, Shu Z, Sekar PK, Li S, Gao D. Determination of the Membrane Transport Properties of Jurkat Cells with a Microfluidic Device. MICROMACHINES 2019; 10:mi10120832. [PMID: 31795446 PMCID: PMC6952789 DOI: 10.3390/mi10120832] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/25/2019] [Revised: 11/22/2019] [Accepted: 11/26/2019] [Indexed: 12/21/2022]
Abstract
The Jurkat cell is an immortalized line of human acute lymphocyte leukemia cells that is widely used in the study of adoptive cell therapy, a novel treatment of several advanced forms of cancer. The ability to transport water and solutes across the cell membrane under different temperatures is an important factor for deciding the specific protocol for cryopreservation of the Jurkat cell. In this study we propose a comprehensive process for determination of membrane transport properties of Jurkat cell. using a novel microfluidic controlled single cell-trapping system. The osmotic behavior of an individual Jurkat cell to water and dimethyl sulfoxide (DMSO), a commonly used cryoprotective agent (CPA), under constant temperature, was recorded under a microscope utilizing the modified microfluidic system. The images of the Jurkat cell under osmotic change were processed to obtain a relationship between cell volume change and time. The experimental results were fitted using a two-parameter transport numeric model to calculate the Jurkat cell membrane permeability to water and DMSO at room temperature (22 °C). This model and the calculated parameters can help scientists optimize the cryopreservation protocol for any cell type with optimal cryoprotective agents and cooling rate for future experiments.
Collapse
Affiliation(s)
- Tianhang Yang
- Department of Fluid Control and Automation, Harbin Institute of Technology, Harbin 150001, Heilongjiang, China;
- Mechanical Engineering, University of Washington, Seattle, WA 98195, USA; (J.P.); (Z.S.); (P.K.S.)
| | - Ji Peng
- Mechanical Engineering, University of Washington, Seattle, WA 98195, USA; (J.P.); (Z.S.); (P.K.S.)
| | - Zhiquan Shu
- Mechanical Engineering, University of Washington, Seattle, WA 98195, USA; (J.P.); (Z.S.); (P.K.S.)
- School of Mechanical and Materials Engineering, Washington State University, Everett, WA 98201, USA
| | - Praveen K. Sekar
- Mechanical Engineering, University of Washington, Seattle, WA 98195, USA; (J.P.); (Z.S.); (P.K.S.)
| | - Songjing Li
- Department of Fluid Control and Automation, Harbin Institute of Technology, Harbin 150001, Heilongjiang, China;
- Correspondence: (S.L.); (D.G.); Tel.: +86-451-86418318 (S.L.); +1-206-543-1411 (D.G.)
| | - Dayong Gao
- Mechanical Engineering, University of Washington, Seattle, WA 98195, USA; (J.P.); (Z.S.); (P.K.S.)
- Correspondence: (S.L.); (D.G.); Tel.: +86-451-86418318 (S.L.); +1-206-543-1411 (D.G.)
| |
Collapse
|
5
|
Chen CW, Hu S, Tsui KH, Hwang GS, Chen ST, Tang TK, Cheng HT, Yu JW, Wang HC, Juang HH, Wang PS, Wang SW. Anti-inflammatory Effects of Gossypol on Human Lymphocytic Jurkat Cells via Regulation of MAPK Signaling and Cell Cycle. Inflammation 2019; 41:2265-2274. [PMID: 30136021 DOI: 10.1007/s10753-018-0868-6] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Gossypol, a natural polyphenolic compound extracted from cottonseed oil, has been reported to possess pharmacological properties via modulation cell cycle and immune signaling pathway. However, whether gossypol has anti-inflammatory effects against phytohemagglutinin (PHA)-induced cytokine secretion in T lymphocytes through similar mechanism remains unclear. Using the T lymphocytes Jurkat cell line, we found that PHA exposure caused dramatic increase in interleukin-2 (IL-2) mRNA expression as well as IL-2 secretion. All of these PHA-stimulated reactions were attenuated in a dose-dependent manner by being pretreated with gossypol. However, gossypol did not show any in vitro cytotoxic effect at doses of 5-20 μM. As a possible mechanism underlying gossypol action, such as pronounced suppression IL-2 release, robust decreased PHA-induced phosphorylation of p38 and c-Jun N-terminal kinase expressions was found with gossypol pretreatment, but not significant phosphorylation of extracellular signal-regulated kinase expression. Furthermore, gossypol could suppress the Jurkat cells' growth, which was associated with increased percentage of G1/S phase and decreased fraction of G2 phase in flow cytometry test. We conclude that gossypol exerts anti-inflammatory effects probably through partial attenuation of mitogen-activated protein kinase (phosphorylated JNK and p38) signaling and cell cycle arrest in Jurkat cells.
Collapse
Affiliation(s)
- Chien-Wei Chen
- Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China
| | - Sindy Hu
- Aesthetic Medical Center, Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.,Department of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan
| | - Ke-Hung Tsui
- Department of Urology, Division of Geriatric Urology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan.,Bioinformation Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
| | - Guey-Shyang Hwang
- Aesthetic Medical Center, Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.,Department of Nursing, Chang Gung University of Science and Technology, Taoyuan, Taiwan.,Department of Nutrition and Health Sciences, Chang Gung University of Science and Technology, Taoyuan, Taiwan
| | - Szu-Tah Chen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
| | - Tswen-Kei Tang
- Department of Nursing, National Quemoy University, Kinmen County, Taiwan
| | - Hao-Tsai Cheng
- Division of Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan.,Graduate Institute of Clinical Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan
| | - Ju-Wen Yu
- Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China
| | - Hsiao-Chiu Wang
- Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China
| | - Horng-Heng Juang
- Bioinformation Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan.,Department of Anatomy, College of Medicine, Chang Gung University, Taoyuan, Taiwan
| | - Paulus S Wang
- Medical Center of Aging Research, China Medical University Hospital, Taichung, Taiwan, Republic of China. .,Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan. .,Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China.
| | - Shyi-Wu Wang
- Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China. .,Aesthetic Medical Center, Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
| |
Collapse
|
6
|
Hu S, Chen CW, Chen ST, Tsui KH, Tang TK, Cheng HT, Hwang GS, Yu JW, Li YC, Wang PS, Wang SW. Inhibitory effect of berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells. Int Immunopharmacol 2018; 66:267-273. [PMID: 30502647 DOI: 10.1016/j.intimp.2018.11.020] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2018] [Revised: 11/13/2018] [Accepted: 11/14/2018] [Indexed: 02/06/2023]
Abstract
Berberine is an isoquinoline alkaloid isolated from herb plants, such as Cortex phellodendri (Huangbai) and Rhizoma coptidis (Huanglian). Huanglian and Huangbai have been used as "heat-removing" agents. In addition, berberine has been reported to exert anti-inflammatory effect both in vivo and in vitro, where mitogen-activated protein kinase (MAPK) and cyclooxygenase-2 (COX-2) expressions are critically implicated. We herein tested the hypothesis that berberine exerts an anti-inflammatory effect through MAPK and COX-2 signaling pathway in T-cell acute lymphoblastic leukemia (T-ALL). In Jurkat cells, we found that PHA exposure caused elevation on interleukin-2 (IL-2) production in a time-dependent manner. PHA-stimulated reactions were steeply suppressed by berberine, such as IL-2 mRNA expression and protein secretion. However, berberine did not exert any cytotoxic effect at doses of 40 μg/ml. In addition, the possible molecular mechanism of anti-inflammation effect of berberine could be the inhibition of PHA-evoked phosphorylation of p38, since c-Jun N-terminal kinases (JNK) and extracellular signal-regulated kinase (ERK) expressions did not alter. Consistent with above results, berberine inhibition on PHA-induced IL-2 secretion could be reversed by treatment of SB203580, a specific inhibitor of p38-MAPK. Interestingly, upregulation of PHA-induced COX-2 expression was also observed following berberine treatment of Jurkat cells. Furthermore, flow cytometry analysis showed berberine-induced cell cycle arrest at G1 phase after PHA stimulation and decreased percentage of G2/M phase. In conclusion, our study demonstrated that the anti-inflammatory effect of berberine largely potentially results from its ability to attenuate p38 MAPK expression, and does not exclude a positive action of berberine on cell cycle arrest. These results provide an innovative medicine strategy to against or treat T-ALL patients.
Collapse
Affiliation(s)
- Sindy Hu
- Aesthetic Medical Center, Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Republic of China; Department of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China
| | - Chien-Wei Chen
- Department of Physiology and Pharmacology, Chang Gung University, Taoyuan, Taiwan, Republic of China
| | - Szu-Tah Chen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Republic of China
| | - Ke-Hung Tsui
- Department of Urology, Division of Geriatric Urology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan, Republic of China; Bioinformation Center, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, Republic of China
| | - Tswen-Kei Tang
- Department of Nursing, National Quemoy University, Kinmen County, Taiwan, Republic of China
| | - Hao-Tsai Cheng
- Division of Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan, Republic of China; Graduate Institute of Clinical Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan, Republic of China
| | - Guey-Shyang Hwang
- Aesthetic Medical Center, Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Republic of China; Department of Nursing, Chang Gung University of Science and Technology, Taoyuan, Taiwan, Republic of China; Department of Nutrition and Health Sciences, Chang Gung University of Science and Technology, Taoyuan, Taiwan, Republic of China
| | - Ju-Wen Yu
- Department of Physiology and Pharmacology, Chang Gung University, Taoyuan, Taiwan, Republic of China
| | - Yi-Chieh Li
- Department of Physiology and Pharmacology, Chang Gung University, Taoyuan, Taiwan, Republic of China
| | - Paulus S Wang
- Medical Center of Aging Research, China Medical University Hospital, Taichung, Taiwan, Republic of China; Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan, Republic of China; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China.
| | - Shyi-Wu Wang
- Aesthetic Medical Center, Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Republic of China; Department of Physiology and Pharmacology, Chang Gung University, Taoyuan, Taiwan, Republic of China.
| |
Collapse
|
7
|
Chang MC, Wu JY, Liao HF, Chen YJ, Kuo CD. Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: A quantitative pilot study. Medicine (Baltimore) 2016; 95:e4467. [PMID: 27495082 PMCID: PMC4979836 DOI: 10.1097/md.0000000000004467] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Abstract
The therapeutic safety of an anticancer drug is one of the most important concerns of the physician treating the cancer patient. Half maximal inhibitory concentration (IC50) and hillslope are usually used to represent the strength and sensitivity of an anticancer drug on cancer cells. The therapeutic safety of the anticancer drug can be assessed by comparing the IC50 and hillslope of anticancer drugs on cancer cells relative to normal cells. Since there are situations where "more anticancer activity" implies "more toxicity," the safety of an anticancer drug in these situations is hard to evaluate by using IC50 and hillslope alone. In a previous study, the "net effect" index was devised to represent the net therapeutic effects of one anticancer drug relative to the other. However, the therapeutic safety of one specific anticancer drug alone was not defined in the "net effect" index. This study introduced the "safety index (SI)" to quantify the degree of safety of an anticancer drug by using 4-parameter logistic model on cancer cells relative to normal cells. The therapeutic safety of norcantharidin (NCTD), N-farnesyloxy-norcantharimide (NOC15), and N-farnesyl-norcantharimide (NC15) in the treatment of Jurkat T cells relative to human normal lymphoblast was compared using the newly defined SI. We found that the SI of NOC15 and NC15 was significantly higher than that of NCTD, suggesting that both NOC15 and NC15 can damage more cancer cells and less normal cells than NCTD. We conclude that both NOC15 and NC15 are safer anticancer drugs than NCTD in the treatment of Jurkat T cells relative to human normal lymphoblast. The SI can be further applied to the screening, developments, and applications of anticancer drugs in the future.
Collapse
Affiliation(s)
- Ming-Che Chang
- Laboratory of Biophysics, Department of Medical Research, Taipei Veterans General Hospital, Taipei
| | - Jin-Yi Wu
- Department of Microbiology, Immunology and Biopharmaceutics, College of Life Sciences
| | - Hui-Fen Liao
- Department of Molecular Biology and Biochemistry, National Chiayi University, Chiayi
| | - Yu-Jen Chen
- Department of Radiation Oncology, Mackay Memorial Hospital, Taipei
| | - Cheng-Deng Kuo
- Laboratory of Biophysics, Department of Medical Research, Taipei Veterans General Hospital, Taipei
- Chest Medicine and Physiological Signals Research Center, Changhua Christian Hospital, Changhua, Taiwan
- Correspondence: Cheng-Deng Kuo, Chest Medicine and Physiological Signals Research Center, Changhua Christian Hospital, Changhua 500, Taiwan (e-mail: )
| |
Collapse
|